Role of maternal bariatric surgery in programming cardio-metabolic disease in growth-restricted offspring
Role of maternal bariatric surgery in programming cardio-metabolic disease in growth-restricted offspring
批准号:
9211438
负责人:
Bernadette E Grayson
金额:
$27.09万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-08 至 2022-05-31
关键词:
Adverse effectsAgeAndrogensAngiotensinsBasic ScienceBirthBlood PressureBody Weight decreasedCardiovascular DiseasesCell physiologyCharacteristicsChildChild health careClinicalComorbidityDataDevelopmentDoctor of PhilosophyDuodenumEffectivenessEndocrinologistEsophagusExhibitsExposure toFemaleFertilityFetal Growth RetardationGastrectomyGastric BypassGestational AgeGestational DiabetesGlucose IntoleranceGrowthHigh Fat DietHigh birth weight infantHypertensionImpairmentKidneyKidney DiseasesLeptin resistanceLifeLinkMediatingMentorsMentorshipMetabolicMetabolic DiseasesMississippiModelingMolecularObesityOperative Surgical ProceduresOutcomePerinatalPhysiologicalPlasmaPlayPre-EclampsiaPregnancyPremature BirthProceduresRattusRenin-Angiotensin SystemReportingResearchResolutionRiskRisk FactorsRodentRodent ModelRoleSerumSmall for Gestational Age InfantStomachStructure of beta Cell of isletSuggestionTechniquesTestingTestosteroneTubeWomanbariatric surgerycardiometabolic riskcardiovascular healthchild bearingearly onsetexperimental studyhigh riskhuman datamalemortalityneonatal deathnoveloffspringpostnatalprenatal exposureprograms
中文摘要
项目二格雷森
英文摘要
Project 2 Grayson ABSTRACT
Role of maternal bariatric surgery in programming cardiovascular disease in offspring
Bariatric surgery for long term body weight loss and resolution of obesity-associated comorbidities
has gained popularity in recent decades. Vertical sleeve gastrectomy (VSG) is a surgical weight loss
procedure that resects 80% of the stomach creating a tube linking the esophagus to the
duodenum.Because of the great effectiveness and relative simplicity of the VSG surgery, VSG is now
on the rise in the U.S. >80% of the recipients of VSG are women of whom approximately half are of
child-bearing age. VSG in female rodents has similar characteristics of women undergoing VSG.
Women who have undergone bariatric surgery have a lower risk of gestational diabetes and
preeclampsia, and reduced risk of large-for-gestational age (LGA) babies. However, recent reports
also highlight negative outcomes in women with previous bariatric surgery that include an increased
risk for small-for-gestational age babies (SGA) or IUGR birth at a reduced gestational age or preterm
birth, and still birth or neonatal death. We were the first to show in our model of rodent VSG, that
offspring had IUGR and increased mortality in the absence of identifiable negative outcomes in the
dam. My novel preliminary data indicate that maternal plasma testosterone is increased in VSG
dams during late pregnancy, and we hypothesize that this could play a role in the developmental
programming of increased cardio-renal risk of the IUGR offspring. This proposal will test the novel
hypothesis that prenatal exposure to increased endogenous levels of testosterone in VSG dams
increases the risk for cardio-metabolic abnormalities in male and female IUGR offspring. (1) We will
test the hypothesis that fetal exposure to elevated maternal endogenous levels of testosterone in
VSG dams programs glucose intolerance mediated by impaired pancreatic beta cell function and
leptin resistance leading to obesity and hypertension in IUGR offspring. (2) We will test the
hypothesis that fetal exposure to elevated maternal endogenous levels of testosterone in VSG dams
programs activation of the renin-angiotensin system leading to elevated blood pressure in IUGR
offspring.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic Consequences of bariatric surgery on pregnant and lactating rats and th
-
批准号:8196218
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2011
-
负责人:Bernadette E Grayson
-
依托单位:
Metabolic Consequences of bariatric surgery on pregnant and lactating rats and th
-
批准号:8514586
-
项目类别:
-
资助金额:$5.39万
-
财政年份:2011
-
负责人:Bernadette E Grayson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: